Approximately 4,218 Shares Of Pfizer Inc. (PFE) Were Sold By This Insider.


Pfizer Inc. (NYSE:PFE) finished Thursday with an addition of $0.65 to close at $44.57, an upside of 1.48 percent. An average of 19,653,559 shares of common stock have been traded in the last five days. There was a fall of -$1.37 in the past week, and it reached a new high 15 times over the past 12 months. The last 20 days have seen an average of 17,581,725 shares traded, while the 50-day average volume stands at 17,822,551.

PFE stock has decreased by -7.17% in the last month. The company shares reached their 1-month lowest point of $43.52 on 09/22/22. With the stock rallying to its 52-week high on 01/03/22, shares of the company touched a low of $40.94 and a high of $61.71 in 52 weeks. It has reached a new high 1 time so far this year and lost -24.52% or -$14.48 in price. In spite of this, the price is down -27.78% from the 52-week high.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Insider Transactions

108 days have passed since Pfizer Inc. (PFE) last reported insider trading activity. DAMICO JENNIFER B., who is SVP & Controller, most recently acquired $4,218 shares at $53.96 per share on Jun 07. In this transaction, the insider spent $227,603. SVP & Controller, DAMICO JENNIFER B., disposed of 4,000 shares at a price of $50.50 on May 16. The insider now owns more than $202,000 worth of shares. Prior to that, Executive Vice President SAHNI PAYAL went on to Sale 1,408 shares at $49.84 each on May 13. An amount of $70,175 was transacted.

Valuation Metrics

Pfizer Inc. (PFE) has a trailing price-to-earnings (P/E) ratio of 8.59. The stock’s beta is 0.69. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 2.47, the price-to-book (PB) ratio at 2.86, and the price-to-cash flow ratio at 12.75.

The company has a payout ratio of 30.20%. The company’s most recent quarterly dividend payment was $0.40 a share, without any change from last year. Its latest increase dividend $0.01 reported on Friday December 10 2021.

Financial Health

The quick ratio of Pfizer Inc. for the three months ended June 29 was 1.20, and the current ratio was 1.40, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.39 and a total debt to equity ratio of 0.46 for the quarter ending June 29. Its gross profit as reported stood at $50.47 billion compared to revenue of $81.29 billion.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Pfizer Inc.’s return on assets was 15.80%.

Earnings Surprise

For the three-month period that ended June 29, Pfizer Inc. had $31.52 billion in cash and short-term investments compared to $34.29 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $9.91 billion in the quarter, while revenues of $7.86 billion were grew 43.84%. The analyst consensus anticipated Pfizer Inc.’s latest quarter earnings to come in at $1.78 per share, but it turned out to be $2.04, a 14.60% surprise. For the quarter, EBITDA amounted to $13.39 billion. Shareholders own equity worth $5.61 billion.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Pfizer Inc. (PFE) price momentum. RSI 9-day as of the close on 22 September was 34.74%, suggesting the stock is Neutral, with historical volatility in this time frame at 19.88%.

As of today, PFE’s price is $44.95 -2.98% or -$1.37 from its 5-day moving average. PFE is currently trading -6.03% lower than its 20-day SMA and -9.17% lower than its 100-day SMA. However, the stock’s current price level is -13.94% below the SMA50 and -13.42% below the SMA200.

The stochastic %K and %D were 10.21% and 12.54%, respectively, and the average true range (ATR) was 1.06. With the 14-day stochastic at 21.74% and the average true range at 1.05, the RSI (14) stands at 36.16%. The stock has reached -1.22 on the 9-day MACD Oscillator while the 14-day reading was at -1.53.

Analyst Ratings

SVB Leerink launched coverage on Pfizer Inc. (NYSE: PFE) in its analyst report released on May 23, 2022. The firm assigned the stock a Mkt perform rating.


Please enter your comment!
Please enter your name here